Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 7/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.40 |
| ▸ | NPY1R | P25929 | 6/20 | 0.40 |
| ▸ | NPY2R | P49146 | 4/20 | 0.40 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.39 |
| ▸ | TFPI | P10646 | 1/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | NMT2 | O60551 | 1/20 | 0.35 |
| ▸ | NMT1 | P30419 | 1/20 | 0.35 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30120984 | 1.00 | NPY4R (0.40) | NPY4RNPY5RNPY1RNPY2RQRFPR | |
| SCHEMBL29482452 | 0.94 | NPY4R (0.43) | NPY4RNPY5RNPY1RNPY2RSLC15A2 | |
| SCHEMBL30120973 | 0.94 | NPY4R (0.43) | NPY4RNPY5RNPY1RNPY2RSLC15A2 | |
| SCHEMBL29875551 | 0.92 | C3AR1 (0.40) | NPY4RNPY5RNPY1RNPY2RQRFPR | |
| SCHEMBL31670642 | 0.91 | GNPAT (0.41) | NPY4RNPY5RNPY1RNPY2RQRFPR | |
| SCHEMBL29736266 | 0.90 | SLC15A2 (0.47) | NPY4RNPY5RNPY1RNPY2RSLC15A2 | |
| SCHEMBL30562993 | 0.90 | SLC15A2 (0.47) | NPY4RNPY5RNPY1RNPY2RSLC15A2 | |
| SCHEMBL29712681 | 0.90 | SLC15A2 (0.47) | NPY4RNPY5RNPY1RNPY2RSLC15A2 | |
| SCHEMBL17930107 | 0.90 | SLC15A2 (0.47) | NPY4RNPY5RNPY1RNPY2RQRFPR | |
| SCHEMBL29614393 | 0.90 | SLC15A2 (0.47) | NPY4RNPY5RNPY1RNPY2RSLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4314016-A1 | CYCLIC CELL PENETRATING PEPTIDES | Entrada Therapeutics, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2022213118-A1 | CYCLIC CELL PENETRATING PEPTIDES | ENTRADA THERAPEUTICS, INC. (US) | 2022-10-06 | — | — | WO | claimed |
| EP-4314016-A1 | CYCLIC CELL PENETRATING PEPTIDES | Entrada Therapeutics, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022213118-A1 | CYCLIC CELL PENETRATING PEPTIDES | ENTRADA THERAPEUTICS, INC. (US) | 2022-10-06 | — | — | WO | disclosed |